Details

Use of conjugate pneumococcal vaccine – 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults: NACI recommendations: Economic evidence supplementary appendixrecommendations. - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Apr 18, 2025 · edition #1
Timestamp: 2025-04-18T19:07:01.623Z
Language: en
Original URL: https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/public-health-level-recommendations-use-pneumococcal-vaccines-adults-including-use-15-valent-20-valent-conjugate-vaccines/economic-evidence-supplementary-appendix.html?wbdisable=false
Replay URL: https://replay.healtharchive.ca/job-1/20250418190701/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/public-health-level-recommendations-use-pneumococcal-vaccines-adults-including-use-15-valent-20-valent-conjugate-vaccines/economic-evidence-supplementary-appendix.html?wbdisable=false#ha_snapshot=231192
ID: 231192
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots